The Bloodline with Blood Cancer United Podcast Podcast Por Blood Cancer United arte de portada

The Bloodline with Blood Cancer United Podcast

The Bloodline with Blood Cancer United Podcast

De: Blood Cancer United
Escúchala gratis

A podcast for patients and caregiversThe Bloodline with LLS - Blood Cancer United Ciencia Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • A Young Adult Story: Cancer, Connection, and Life After Treatment

    A Young Adult Story: Cancer, Connection, and Life After Treatment
    Apr 5 2026
    Chris Pagliarulo A cancer diagnosis in your 20s or 30s can raise questions most people never expect to face so early in life. In this episode, we speak with Chris Pagliarulo, who was diagnosed with Hodgkin lymphoma at the age of 29, about the medical, emotional, and practical realities of cancer during early adulthood. We explore issues that are especially relevant for adolescent and young adult (AYA) patients, including delayed diagnosis, fertility preservation, treatment side effects, career disruption, relationships, and finding connection with others who understand. While this conversation highlights experiences unique to AYAs, patients and caregivers of all ages may hear pieces of their own experience reflected in what Chris shares. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Young Adult ResourcesHodgkin lymphomaFertility and family planning resourcesPatti Robinson Kauffman First Connection®Light The Night Additional Blood Cancer United Support Resources: Information Specialists Financial supportOnline ChatFree Nutrition ConsultationsFree telephone/web patient programs Free booklets Clinical Trial Support CenterSupport groups Caregiver support Caregiver WorkbookSurvivorship WorkbookAdvocacy and Public PolicyPatient CommunityMental Health ResourcesThe post A Young Adult Story: Cancer, Connection, and Life After Treatment first appeared on The Bloodline with Blood Cancer United Podcast.
    Más Menos
    38 m
  • Acute Lymphoblastic Leukemia (ALL): The New Tools Shaping Tomorrow

    Acute Lymphoblastic Leukemia (ALL): The New Tools Shaping Tomorrow
    Mar 31 2026
    Marlise Luskin, MD With so many new advances in acute lymphoblastic leukemia (ALL), understanding today’s treatment landscape can give patients a clearer, more hopeful outlook. In this episode, we speak with Marlise Luskin, MD of the Dana-Farber Cancer Institute, about what adults should know when facing a diagnosis of acute lymphoblastic leukemia. Dr. Luskin helps listeners understand how ALL develops, how subtypes are identified, and why genetics play an important role in guiding treatment. She discusses current therapies including chemotherapy, targeted agents and immunotherapies including CAR T-cell therapy, as well as how care teams monitor progress and manage side effects. While ALL is a complex disease, patients and caregivers will hear clear explanations, practical information, and meaningful reasons to feel hopeful about the advances shaping ALL care today. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Acute lymphoblastic leukemia (ALL)Minimal/measurable residual disease (MRD) fact sheetAllogeneic stem cell transplantationClinical Trial Support CenterALL Children and Teens booklet Additional Blood Cancer United Support Resources: Information Specialists Financial supportOnline ChatFree Nutrition ConsultationsFree telephone/web patient programs Free booklets Support groups Caregiver support Caregiver WorkbookYoung Adult ResourcesSurvivorship WorkbookAdvocacy and Public PolicyPatient CommunityMental Health Resources Episode supported by Syndax Pharmaceuticals Inc. The post Acute Lymphoblastic Leukemia (ALL): The New Tools Shaping Tomorrow first appeared on The Bloodline with Blood Cancer United Podcast.
    Más Menos
    42 m
  • Facing Multiple Myeloma: A Guide to Choices, Care, and Confidence

    Facing Multiple Myeloma: A Guide to Choices, Care, and Confidence
    Mar 12 2026
    Andrew Yee, MD Multiple myeloma can feel unfamiliar and overwhelming at first, but today’s advances tell a much brighter story. In this episode, Dr. Andrew Yee of Massachusetts General Hospital explains what myeloma is, how it’s diagnosed, and why new treatment options, from four-drug regimens to CAR T-cell therapy and bispecific antibodies, are transforming patient outcomes. With enthusiasm and relatable analogies, he highlights how patients may progress from periods of significant challenges to reaching a level of stability and well‑being that allows them to live fully. This conversation offers clarity, confidence, and real optimism for anyone navigating myeloma. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Multiple myelomaAmyloidosisAutologous stem cell transplantationCAR T-cell therapyImmunotherapy fact sheetClinical Trial Support Center Additional Blood Cancer United Support Resources: Information Specialists Financial supportOnline ChatFree Nutrition ConsultationsFree telephone/web patient programs Free booklets Young Adult ResourcesSupport groups Caregiver support Caregiver WorkbookSurvivorship WorkbookAdvocacy and Public PolicyPatient CommunityMental Health Resources Episode supported by AbbVie Inc.; Bristol Myers Squibb; Genentech, A Member of the Roche Group; GSK plc.; Johnson & Johnson. The post Facing Multiple Myeloma: A Guide to Choices, Care, and Confidence first appeared on The Bloodline with Blood Cancer United Podcast.
    Más Menos
    51 m
Todavía no hay opiniones